Laser treatment for long-lasting central serous eye fluid
Part of Eyes & vision clinical trials.
This trial tests a low-energy “subthreshold” laser to treat long-lasting fluid under the retina from central serous chorioretinopathy (CSCR). It may help dry up the fluid and improve vision, compared with a sham (placebo) treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- Your CSCR is long-lasting (eye fluid seen on an OCT scan for more than 3 months)
- Your eyesight in the study eye falls within a specific range (about 6/6 to 6/60)
- You can understand the study and attend all scheduled visits
- You are able to safely have the pupil dilated for eye exams and laser/sham treatment
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
This trial compares two treatments for chronic central serous chorioretinopathy (CSC), a condition that causes fluid buildup under the retina. It tests whether adding a light therapy (photodynamic therapy) to micropulse laser treatment helps improve vision more than laser alone.
This study is testing whether mindfulness-based stress reduction can help people with central serous chorioretinopathy (CSCR), a condition causing fluid buildup under the retina. If you have active CSCR that started recently, you might be eligible.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.
This trial tests whether taking oral melatonin (a natural hormone) can help treat central serous chorioretinopathy, a condition where fluid builds up under the retina and blurs vision. It may be a good fit if you were recently diagnosed and haven't had certain eye procedures recently.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.